Sign in
4

Changes in Ownership

AIM ImmunoTech Inc. Filed Acc 0001450324-22-000002

CEO & President acquired 49,020 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Equels Thomas K CEO & President 2022-04-25 Grant or award +49,020 $1.02 $50,000 349,809 D
Loading xslF345X03/primary_doc.xml…